Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
about
Improved prediction of complex diseases by common genetic markers: state of the art and further perspectivesThe role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision makingTERT-CLPTM1L polymorphism rs401681 contributes to cancers risk: evidence from a meta-analysis based on 29 publicationsImpact of prostate-specific antigen on a baseline prostate cancer risk assessment including genetic risk.Prostate cancer in young men: an important clinical entity.Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese.Poor reproducibility of allergic rhinitis SNP associations.Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy.Association between EHBP1 rs721048(A>G) polymorphism and prostate cancer susceptibility: a meta-analysis of 17 studies involving 150,678 subjectsMicroseminoprotein-Beta Expression in Different Stages of Prostate Cancer.An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortalityInfluence of age on predictiveness of genetic risk score for prostate cancer in a Chinese hospital-based biopsy cohort.A personalised approach to prostate cancer screening based on genotyping of risk founder allelesThe PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate CancerProstate cancer risk-associated genetic markers and their potential clinical utilityPopulation-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.Association between 17q25.3-rs6465657 polymorphism and prostate cancer susceptibility: a meta-analysis based on 19 studiesReplication study of 34 common SNPs associated with prostate cancer in the Romanian population.Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young menGenome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.Beyond prostate-specific antigen: utilizing novel strategies to screen men for prostate cancer.Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men.The presence of prostate cancer at biopsy is predicted by a number of genetic variants.Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.
P2860
Q26770167-DEA5C377-D284-48AE-A481-59C68ADF0B1EQ27025062-FDBE035F-8EB6-4C2E-B87B-B66E29B27AC5Q28391602-794E15E1-A051-4F3D-B753-DDAFEAD49E3EQ33585860-0C87E2EE-4EB9-4FCC-884E-C637302FEBD1Q34314644-F321AE17-D2C9-4D83-A924-7950B9F181EDQ34447165-B746956D-FADE-4EF8-8ACA-5BA3C3C1AF48Q34575297-4224C209-1445-4CA3-93BF-FC1D38E62538Q35796865-0D2C7158-E331-4A63-923C-F747A7895587Q35846834-1B8715E8-5FBE-4A82-9421-69183FB4A516Q35944835-1EC8326E-FBA3-4A07-98BB-E6CFDC196058Q36286694-AA60FC67-BA50-4060-8A12-6E5F989797BEQ36356134-C66B52D2-BDCB-4EC0-A84D-193B7D26ED94Q36959139-884B0F2F-4D7C-4CF6-BFA3-9D78B7F28387Q37017011-657718AF-D3B4-48B0-AC22-477B2EF750C5Q37085446-726ABEF6-C604-4CE7-B914-4BA9BC2840D2Q37113165-476AB70A-461C-448C-8EEE-C749B5733662Q37138670-C64E5D23-A033-4984-A65C-74975CA0B593Q37447848-9E20F5CC-410F-403D-909E-8FB436137F2BQ37541989-E692D198-D39D-46B3-A483-33A87B72B69AQ37619482-615506D8-9D26-406C-80CD-D7C3390AA107Q37622580-89E99382-DFAC-47F6-9E0D-C584E0D97CD3Q38854599-B05FE3EC-02FD-4EB0-A00D-7AA96B4432A6Q40051613-66E20B0A-5E17-462B-B9B4-138B4EECA23DQ40137412-E230515D-77A9-47B7-A564-35534878A8DBQ40152616-66AF6DB6-5A39-4F26-9369-A4A4558B89F3Q40281207-6752323C-5E66-443C-B42C-9A07BAA242EF
P2860
Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Evaluation of multiple risk-as ...... tate cancer in unscreened men.
@ast
Evaluation of multiple risk-as ...... tate cancer in unscreened men.
@en
type
label
Evaluation of multiple risk-as ...... tate cancer in unscreened men.
@ast
Evaluation of multiple risk-as ...... tate cancer in unscreened men.
@en
prefLabel
Evaluation of multiple risk-as ...... tate cancer in unscreened men.
@ast
Evaluation of multiple risk-as ...... tate cancer in unscreened men.
@en
P2093
P2860
P50
P1433
P1476
Evaluation of multiple risk-as ...... state cancer in unscreened men
@en
P2093
Amit Gupta
Anders Bjartell
Anders Dahlin
Caroline J Savage
Christer Hallden
Jonas Manjer
Peter T Scardino
Peter Wallström
Robert J Klein
P2860
P304
P356
10.1016/J.EURURO.2011.10.047
P407
P577
2011-11-07T00:00:00Z